Optical Imaging of Oral Squamous Cell Carcinoma Using Optical Coherence Tomography and Micro CT


Article Preview

Oral squamous cell carcinoma (OSCC) constitutes 90% of oral cancer. Early detection is a cornerstone to improve survival and to reduce diagnostic delay. We propose optical coherence tomography (OCT), as a non-invasive diagnosis method. OCT represents a new high-resolution optical technique that permits 3D, real-time imaging of near surface abnormalities in complex tissues. In the present study half of the excisional biopsy was directed to the pathologist and the other half was assigned for OCT and Micro-CT investigation. For the OCT imaging it was used an OCT prototype (1300 nm), Synchrotron Radiation Micro-CT and histopathology validated the results. Areas of OSCC of the buccal mucosa were identified in the OCT images by the disruption of the basement membrane, an epithelial layer that was highly variable in thickness, with areas of erosion, extensive epithelial down-growth and invasion into the sub-epithelial layers. In this respect, OCT seems to be a highly promising imaging modality.



Main Theme:

Edited by:

Iulian Antoniac, Simona Cavalu and Teodor Traistaru




S. Cânjău et al., "Optical Imaging of Oral Squamous Cell Carcinoma Using Optical Coherence Tomography and Micro CT", Key Engineering Materials, Vol. 587, pp. 331-337, 2014

Online since:

November 2013




[1] Mashberg A, Samit A, Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers, CA Cancer J. Clin. 45 (1995) 328-351.

DOI: https://doi.org/10.3322/canjclin.45.6.328

[2] Sankaranarayanan R, Fernandez GL, Lence AJ, Pisani P, Rodriguez SA, Visual inspection in oral cancer screening in Cuba: A case-control study, Oral Oncol. 38 (2002) 131-136.

[3] Shugars DC, Patton LL, Detecting, diagnosing, and preventing oral cancer, Nurse Pract. 22 (1997) 105 109-10 113-115.

DOI: https://doi.org/10.1097/00006205-199706000-00007

[4] Silverman S Jr, Early diagnosis of oral cancer, Cancer 62 (1988) 1796-1799.

[5] Woolgar J, A pathologist's view of oral cancer in the North West, Br. Dent. J. 54 (1995) 14-16.

[6] Sciubba JJ. Oral cancer, The importance of early diagnosis and treatment, Am. J. Clin. Dermatol. 2 (2001) 239-251.

[7] US Preventive Services Task Force, Guide to clinical preventive services, ed. Williams and Wilkins Baltimore, (1996).

[8] Califano J, Westra WH, Meininger G, Corio R, Koch WM, Sidransky D, Genetic progression and clonal relationship of recurrent premalignant head and neck lesions, Clin. Cancer Res. 6 (2000) 347-352.

[9] Braakhuis BJ, Leemans CR, Brakenhoff RH, A genetic progression model of oral cancer: Current evidence and clinical implications, J Oral Pathol. Med. 33 (2004) 317-322.

[10] Fischer DJ, Epstein JB, Morton TH, Schwartz SM, Interobserver reliability in the histopathologic diagnosis of oral premalignant and malignant lesions, J Oral Pathol Med 33 (2004) 65-70.

DOI: https://doi.org/10.1111/j.1600-0714.2004.0037n.x

[11] Fischer DJ, Epstein JB, Morton TH, Schwartz SM, Reliability of histologic diagnosis of clinically normal intraoral tissue adjacent to clinically suspicious lesions in former upper aerodigestive tract cancer patients, Oral Oncol 41 (2005) 489-496.

[12] Zhang L, Williams M, Poh CF, Laronde D, Epstein J, Durham S, Nakamura H, Berean K, Hovan A, Le ND, Hislop G, Priddy R, Hay J, Lam WL, Rosin MP, Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome, Cancer Res. 65 (2005).

DOI: https://doi.org/10.1158/0008-5472.can-04-3153

[13] Guo Z, Yamaguchi K, Sanchez-Cespedes M, Westra WH, Koch WM, Sidransky D, Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy, Clin Cancer Res. 7 (2001) 1963-(1968).

[14] Crispian Scully, José V. Bagan, Colin Hopper, Joel B. Epstein, Oral cancer: Current and future diagnostic techniques, American Journal of Dentistry 21 (2008) 199-209.

[15] Rosin MP, Epstein JB, Berean K, Durham S, Hay J, Cheng X, Zeng T, Huang Y, Zhang L, The use of exfoliative cell samples to map clonal genetic alterations in the oral epithelium of high-risk patients, Cancer Res. 57 (1997) 5258-5260.

[16] Spafford MF, Koch WM, Reed AL, Califano JA, Xu LH, Eisenberger CF, Yip L, Leong PL, Wu L, Liu SX, Jeronimo C, Westra WH, Sidransky D, Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis, Clin Cancer Res 7 (2001).

[17] Swinson B, Jerjes W, El-Maaytah M, Norris P, Hopper C, Optical techniques in diagnosis of head and neck malignancy, Oral Oncol. 42 (2006) 221-228.

DOI: https://doi.org/10.1016/j.oraloncology.2005.05.001

[18] Suhr MA, Hopper C, Jones L, George JG, Bown SG, MacRobert AJ, Optical biopsy systems for the diagnosis and monitoring of superficial cancer and precancer, Int J OralMaxillofac Surg 29 (2000) 453-457.

DOI: https://doi.org/10.1034/j.1399-0020.2000.290614.x

[19] Wilder-Smith, P., Holtzman, J., Epstein, J., Le, A., Optical diagnostics in the oral cavity: an overview, Oral Diseases 167 (2010) 17-28.

[20] Zaid Hamdoon, Waseem Jerjesa, Tahwinder Upiled, Gordon McKenzied, Amrita Jayd, Colin Hopper, Optical coherence tomography in the assessment of suspicious oral lesions: An immediate ex vivo study, Photodiagnosis and Photodynamic Therapy 10 (2013).

DOI: https://doi.org/10.1016/j.pdpdt.2012.07.005

Fetching data from Crossref.
This may take some time to load.